Literature DB >> 8275635

Velopharyngeal insufficiency and secondary palatal management. A new look at an old problem.

P D Witt1, L L D'Antonio.   

Abstract

The main objective of primary palatoplasty is to achieve adequate velopharyngeal (VP) function and normal oral-nasal resonance. Many children, however, who undergo cleft palate repair fail to develop normal VP function. Symptoms of velopharyngeal insufficiency (VPI), such as hypernasality and audible nasal air emission, may have a variety of causes, which underscores the need for comprehensive evaluation. This article focuses on the problem of VPI and emphasizes the need for differential diagnosis at the most critical step in management planning. The challenge of the future is to implement the team approach, integrating the expertise of speech scientists and plastic surgeons, so that differential diagnosis can and will lead to differential management.

Entities:  

Mesh:

Year:  1993        PMID: 8275635

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  4 in total

1.  Age-Related Changes Between the Level of Velopharyngeal Closure and the Cervical Spine.

Authors:  Kazlin N Mason; Jamie L Perry; John E Riski; Xiangming Fang
Journal:  J Craniofac Surg       Date:  2016-03       Impact factor: 1.046

2.  Management of velopharyngeal insufficiency using double opposing z-plasty in patients undergoing primary two-flap palatoplasty.

Authors:  Kyung Suk Koh; Sung Chan Kim; Tae Suk Oh
Journal:  Arch Plast Surg       Date:  2013-03-11

3.  Magnetic resonance imaging as an aid in the dynamic assessment of the velopharyngeal mechanism in children.

Authors:  Dennis S Kao; David A Soltysik; James S Hyde; Arun K Gosain
Journal:  Plast Reconstr Surg       Date:  2008-08       Impact factor: 4.730

4.  Inspiration After Posterior Pharyngeal Flap Palatoplasty: A Preliminary Study Using Computational Fluid Dynamic Analysis.

Authors:  Chao Yang; Jiang Li; Huo Li; Nan Chen; Xing Yin; Bing Shi; Jingtao Li; Hanyao Huang
Journal:  Front Pediatr       Date:  2022-05-03       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.